{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:03:29Z","timestamp":1766023409795,"version":"3.48.0"},"reference-count":26,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Blood Res"],"DOI":"10.62347\/ykqj8037","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:46:56Z","timestamp":1756439216000},"page":"90-95","source":"Crossref","is-referenced-by-count":0,"title":["Rosai-Dorfman-Destombes disease in an elderly man. A case of necrosis in the lymph node"],"prefix":"10.62347","volume":"15","author":[{"given":"Yasuhiro","family":"Kazuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Rosai J and Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969; 87: 63-70."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","author":"Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J and Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 2018; 131: 2877-2890.","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Tapia N, Sharma S, Koirala M and Blumenthal D. Rosai-Dorfman disease occurring in an elderly patient with long-standing idiopathic hypertrophic osteoarthropathy. J Clin Rheumatol 2021; 27: S713-S714.","DOI":"10.1097\/RHU.0000000000001561"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqad047","article-title":"How I diagnose Rosai-Dorfman disease","volume":"160","author":"Ravindran","year":"2023","unstructured":"Ravindran A and Rech KL. How I diagnose Rosai-Dorfman disease. Am J Clin Pathol 2023; 160: 1-10.","journal-title":"Am J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001617","article-title":"Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2","volume":"45","author":"Ravindran","year":"2021","unstructured":"Ravindran A, Goyal G, Go RS and Rech KL; Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2. Am J Surg Pathol 2021; 45: 35-44.","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/1097-0142(197211)30:5<1174::AID-CNCR2820300507>3.0.CO;2-S","article-title":"Analysis of 34 cases","volume":"30","author":"Rosai","year":"1972","unstructured":"Rosai J and Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972; 30: 1174-1188.","journal-title":"Cancer"},{"key":"ref6","unstructured":"Hayes MM, Daya H, Uys CJ and Samson RI. Sinus histiocytosis with massive lymphadenopathy. Report of a case associated with necrosis. Arch Pathol Lab Med 1985; 109: 151-152."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"JF","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R and Weiss LM; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016; 127: 2672-2681.","journal-title":"Blood"},{"key":"ref8","unstructured":"Kaur PP, Birbe RC and DeHoratius RJ. Rosai-Dorfman disease in a patient with systemic lupus erythematosus. J Rheumatol 2005; 32: 951-953."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Lopetegui-Lia N, Asad SD, Jafri SI and Harrison JS. Autoimmune diseases and Rosai-Dorfman disease coexist more commonly than expected: two case reports. Am J Case Rep 2019: 20: 770-772.","DOI":"10.12659\/AJCR.915627"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/neuonc\/noab107","article-title":"Histiocytosis and the nervous system: from diagnosis to targeted therapies","volume":"23","author":"Cohen Aubart","year":"2021","unstructured":"Cohen Aubart F, Idbaih A, Emile JF, Amoura Z, Abdel-Wahab O, Durham BH, Haroche J and Diamond EL. Histiocytosis and the nervous system: from diagnosis to targeted therapies. Neuro Oncol 2021; 23: 1433-1446.","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M, Alaskar A, Gmati G, Damlaj M, Abuelgasim KA, Alghamdi A, Alahmari B, Almugairi A, Alzahrani H, Bazarbachi A, Musa MOH and Goyal G. Highlights of the management of adult histiocytic disorders: langerhans cell histiocytosis, erdheim-chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 2021; 21: e66-e75.","DOI":"10.1016\/j.clml.2020.08.007"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","article-title":"Sutimlimab in cold agglutinin disease","volume":"384","author":"R&#xF6","year":"2021","unstructured":"R&#xF6;th A, Barcellini W, D&#x2019;Sa S, Miyakawa Y, Broome CM, Michel M, Kuter DJ, Jilma B, Tvedt THA, Fruebis J, Jiang X, Lin S, Reuter C, Morales-Arias J, Hobbs W and Berentsen S. Sutimlimab in cold agglutinin disease. N Engl J Med 2021; 384: 1323-1334.","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12890-020-01336-y","article-title":"Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features","volume":"20","author":"Wang","year":"2020","unstructured":"Wang J, Zheng P, Huang Z, Huang H, Xue M, Liao C, Sun B and Zhong N. Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 2020; 20: 315.","journal-title":"BMC Pulm Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2169\/internalmedicine.56.7609","article-title":"Rosai-Dorfman disease of the lung overlapping with IgG4-related disease: the difficulty in its differential diagnosis","volume":"56","author":"Hasegawa","year":"2017","unstructured":"Hasegawa M, Sakai F, Okabayashi A, Katsura H, Kamata T, Koh E, Sekine Y, Takemura T, Nakatani Y and Hiroshima K. Rosai-Dorfman disease of the lung overlapping with IgG4-related disease: the difficulty in its differential diagnosis. Intern Med 2017; 56: 937-941.","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13019-020-1085-6","article-title":"Rosai-Dorfman disease with pulmonary involvement mimicking bronchogenic carcinoma","volume":"15","author":"Al-Maghrabi","year":"2020","unstructured":"Al-Maghrabi H, Elmahrouk A, Feteih M, Jamjoom A and Al-Maghrabi J. Rosai-Dorfman disease with pulmonary involvement mimicking bronchogenic carcinoma. J Cardiothorac Surg 2020; 15: 37.","journal-title":"J Cardiothorac Surg"},{"key":"ref16","unstructured":"Sen M, Ruan GJ, Reynolds SB, Ali H, Yang X, Morlote D, Ravindran A, Shea L, Maron R, Elmets CA, Koster MJ, Abeykoon JP, Salama HA, Cao XX, Ahmed AZ, Go RS and Goyal G. A multi-center study of autoimmunity in Rosai Dorfman disease. 40th annual meeting of Histiocyte Society 2024; (Abstract) page 39."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2133.2001.04325.x","article-title":"Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates","volume":"145","author":"Grabczynska","year":"2001","unstructured":"Grabczynska SA, Toh CT, Francis N, Costello C and Bunker CB. Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. Br J Dermatol 2001; 145: 323-326.","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sachdeva M and Abdulhaq H. A rare case of Rosai-Dorfman disease in an adult male associated with auto-immune hemolytic anemia. Mediterr J Hematol Infect Dis 2013; 5: e2013022.","DOI":"10.4084\/mjhid.2013.022"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3109\/10428194.2012.740564","article-title":"Rare coexistence of Rosai-Dorfman disease and nodal marginal zone lymphoma complicated by severe life-threatening autoimmune hemolytic anemia","volume":"54","author":"Akria","year":"2013","unstructured":"Akria L, Sonkin V, Braester A, Cohen HI, Suriu C and Polliack A. Rare coexistence of Rosai-Dorfman disease and nodal marginal zone lymphoma complicated by severe life-threatening autoimmune hemolytic anemia. Leukemia Lymphoma 2013; 54: 1553-1556.","journal-title":"Leukemia Lymphoma"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000485968","article-title":"Rosai-Dorfman disease complicated by autoimmune hemolytic anemia in a child: a case report and review of the literature","volume":"11","author":"Lardhi","year":"2018","unstructured":"Lardhi AA, Al-Mutairi AK, Al-Qahtani MH and Al-Mutairi AK. Rosai-Dorfman disease complicated by autoimmune hemolytic anemia in a child: a case report and review of the literature. Case Rep Oncol 2018; 11: 55-62.","journal-title":"Case Rep Oncol"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Subhadarshani S, Kumar T, Arava S and Gupta S. Rosai-Dorfman disease with cutaneous plaques and autoimmune haemolytic anemia. BMJ Case Rep 2019; 12: e231927.","DOI":"10.1136\/bcr-2019-231927"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12887-020-02368-3","article-title":"Rosai-Dorfman disease with renal involvement and associated autoimmune haemolytic anaemia in a 12-year-old girl: a case report","volume":"20","author":"Danisious","year":"2020","unstructured":"Danisious T, Hettiarachchi M, Dharmadasa C and Jayaweera H. Rosai-Dorfman disease with renal involvement and associated autoimmune haemolytic anaemia in a 12-year-old girl: a case report. BMC Pediatr 2020; 20: 470.","journal-title":"BMC Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1182\/asheducation-2018.1.382","article-title":"Autoimmune hemolytic anemia","volume":"2018","author":"Hill","year":"2018","unstructured":"Hill A and Hill QA. Autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2018; 2018: 382-389.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chest.2019.09.036","article-title":"Lung Involvement in Destombes-Rosai-Dorfman disease: clinical and radiological features and response to the MEK inhibitor cobimetinib","volume":"157","author":"Moyon","year":"2020","unstructured":"Moyon Q, Boussouar S, Maksud P, Emile JF, Charlotte F, Aladjidi N, Pr&#xE9;vot G, Donadieu J, Amoura Z, Grenier P, Haroche J and Cohen-Aubart F. Lung Involvement in Destombes-Rosai-Dorfman disease: clinical and radiological features and response to the MEK inhibitor cobimetinib. Chest 2020; 157: 323-333.","journal-title":"Chest"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1001\/jamaoncol.2022.4432","article-title":"Outcomes after treatment with Cobimetinib in patients with Rosai-Dorfman disease based on KRAS and MEK alteration status","volume":"8","author":"JP","year":"2022","unstructured":"Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G and Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Outcomes after treatment with Cobimetinib in patients with Rosai-Dorfman disease based on KRAS and MEK alteration status. JAMA Oncol 2022; 8: 1816-1820.","journal-title":"JAMA Oncol"}],"container-title":["American Journal of Blood Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajbr\/15\/4\/ajbr0164941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:29Z","timestamp":1766023109000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajbr\/15\/4\/ajbr0164941.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ykqj8037","relation":{},"ISSN":["2160-1992"],"issn-type":[{"type":"electronic","value":"2160-1992"}],"subject":[],"published":{"date-parts":[[2025]]}}}